These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19075887)

  • 1. New aspects in sustained drug release formulations.
    Bikiaris D; Koutris E; Karavas E
    Recent Pat Drug Deliv Formul; 2007; 1(3):201-13. PubMed ID: 19075887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in oral pulsatile drug delivery.
    Kalantzi LE; Karavas E; Koutris EX; Bikiaris DN
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):49-63. PubMed ID: 19149729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guar gum as platform for the oral controlled release of therapeutics.
    Aminabhavi TM; Nadagouda MN; Joshi SD; More UA
    Expert Opin Drug Deliv; 2014 May; 11(5):753-66. PubMed ID: 24650099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermosensitive polymeric hydrogels as drug delivery systems.
    Gong C; Qi T; Wei X; Qu Y; Wu Q; Luo F; Qian Z
    Curr Med Chem; 2013; 20(1):79-94. PubMed ID: 23092130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid excipients - matrix agents for sustained drug delivery.
    Rosiaux Y; Jannin V; Hughes S; Marchaud D
    J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable formulations for an intravitreal sustained-release application of a novel single-chain VEGF antibody fragment.
    Asmus LR; Grimshaw JP; Richle P; Eicher B; Urech DM; Gurny R; Möller M
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):250-60. PubMed ID: 25779352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of in vitro release models in formulation development and quality control of parenteral depots.
    Larsen C; Larsen SW; Jensen H; Yaghmur A; Ostergaard J
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1283-95. PubMed ID: 19941410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable hydrogels for sustained release of therapeutic agents.
    Thambi T; Li Y; Lee DS
    J Control Release; 2017 Dec; 267():57-66. PubMed ID: 28827094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogel formulations for biologicals: current spotlight from a commercial perspective.
    Ickenstein LM; Garidel P
    Ther Deliv; 2018 Feb; 9(3):221-230. PubMed ID: 29424291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems.
    Bale S; Khurana A; Reddy AS; Singh M; Godugu C
    Crit Rev Ther Drug Carrier Syst; 2016; 33(4):309-361. PubMed ID: 27910739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in chitosan films for controlled release of drugs.
    Mengatto LN; Helbling IM; Luna JA
    Recent Pat Drug Deliv Formul; 2012 Aug; 6(2):156-70. PubMed ID: 22436027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site specific chronotherapeutic drug delivery systems: a patent review.
    Saigal N; Baboota S; Ahuja A; Ali J
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):64-70. PubMed ID: 19149730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization.
    Stanković M; Frijlink HW; Hinrichs WL
    Drug Discov Today; 2015 Jul; 20(7):812-23. PubMed ID: 25660507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-controlled pulsatile delivery systems for bioactive compounds.
    Anal AK
    Recent Pat Drug Deliv Formul; 2007; 1(1):73-9. PubMed ID: 19075876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and fabrication of hydrogel-based nanoparticulate systems for in vivo drug delivery.
    Lai WF; He ZD
    J Control Release; 2016 Dec; 243():269-282. PubMed ID: 27746276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
    Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of In Vitro-In Vivo Correlation (IVIVC) to facilitate the development of polymer-based controlled release injectable formulation.
    Mitra A; Wu Y
    Recent Pat Drug Deliv Formul; 2010 Jun; 4(2):94-104. PubMed ID: 20214657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.